Time-domain T-wave alternans is strongly associated with a history of ventricular fibrillation in patients with brugada syndrome

Journal of Cardiovascular Electrophysiology

Volumn 25, Issue 9, 2014, Pages 1021-1027

  Uchimura Makita, Yuko ^a   Nakano, Yukiko ^a   Tokuyama, Takehito ^a   Fujiwara, Mai ^a   Watanabe, Yoshikazu ^a   Sairaku, Akinori ^a   Kawazoe, Hiroshi ^a   Matsumura, Hiroya ^a   Oda, Nozomu ^a   Ikanaga, Hiroki ^a   Motoda, Chikaaki ^a   Kajihara, Kenta ^b   Oda, Noboru ^c   Verrier, Richard L ^d   Kihara, Yasuki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b National Hospital Organization   (Japan)

^c HIROSHIMA CITY ASA HOSPITAL   (Japan)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Ambulatory monitoring; Brugada syndrome; Implantable cardioverter defibrillator; Sudden death; T wave alternans; Ventricular fibrillation

Indexed keywords

ADULT; ARTICLE; BRUGADA SYNDROME; CARDIAC PATIENT; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE MARKER; ELECTROCARDIOGRAM; ELECTROSTIMULATION; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART VENTRICLE FIBRILLATION; HUMAN; INCIDENCE; MALE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; T WAVE; T WAVE ALTERNANS; COMPLICATION; ELECTROCARDIOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; VENTRICULAR FIBRILLATION;

BRUGADA SYNDROME; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VENTRICULAR FIBRILLATION;

EID: 84908147916     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12441     Document Type: Article

References (40)

1. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P: Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-78.
2. Brugada J, Brugada R, Brugada P: Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003;108:3092-3096.
3. Eckardt L, ProbstV, Smits JP, Bahr ES,Wolpert C, Schimpf R,Wichter T, Boisseau P, Heinecke A, Breithardt G, Borggrefe M, LeMarec H, Böcker D, Wilde AA: Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 2005;111:257-263.
4. Morita H, Takenaka-Morita S, Fukushima-Kusano K, Kobayashi M, Nagase S, Kakishita M, Nakamura K, Emori T, Matsubara H, Ohe T: Risk stratification for asymptomatic patients with Brugada syndrome. Circ J 2003;67:312-316.
5. Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL, Babuty D, Sacher F, Giustetto C, Schulze-Bahr E, Borggrefe M, Haissaguerre M, Mabo P, Le Marec H, Wolpert C, Wilde AA: Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation 2010;121:635-643.
6. Priori SG, Gasparini M, Napolitano C, Della Bella P, Ottonelli AG, Sassone B, Giordano U, Pappone C, Mascioli G, Rossetti G, De Nardis R, ColomboM: Risk stratification in Brugada syndrome: Results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol 2012;59:37-45.
7. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C; Document Reviewers, Ackerman M, Belhassen B, Estes NA 3rd, Fatkin D, Kalman J, Kaufman E, Kirchhof P, Schulze-Bahr E, Wolpert C, Vohra J, Refaat M, Etheridge SP, Campbell RM, Martin ET, Quek SC: Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 2013;15:1389-1406.
8. Olde Nordkamp LR,Wilde AA, Tijssen JG, Knops RE, van Dessel PF, de Groot JR: The ICD for primary prevention in patients with inherited cardiac diseases: Indications, use, and outcome: A comparison with secondary prevention. Circ Arrhythm Electrophysiol 2013;6:91-100.
9. Wilde AA, Postema PG, Di Diego JM, Viskin S, Morita H, Fish JM, Antzelevitch C: The pathophysiological mechanism underlying Brugada syndrome: Depolarization versus repolarization. J Mol Cell Cardiol 2010;49:543-553.
10. Ikeda T, Yoshino H, Sugi K, Tanno K, Shimizu H, Watanabe J, Kasamaki Y, Yoshida A, Kato T: Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: Results of a collaborative cohort study. J Am Coll Cardiol 2006;48:2268-2274.
11. Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F; ALPHA Study Group Investigators: Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: Results of the ALPHA Study. J Am Coll Cardiol 2007;50:1896-1904.
12. Verrier RL, Klingenheben T, Malik M, El-Sherif N, Exner DV, Hohnloser SH, Ikeda T,Martínez JP, Narayan SM, Nieminen T, Rosenbaum DS. Microvolt T-wave alternans: Physiologic basis, methods of measurement, and clinical utility. Consensus guideline by the International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol 2011;44:1309-1324.
13. Gehi AK, Stein RH, Metz LD, Gomes JA: Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: Ametaanalysis. J Am Coll Cardiol 2005;46:75-82.
14. Kirchhof P, Eckardt L, Rolf S, Esperer HD, Paul M, Wichter T, Klein HU, Breithardt G, Böcker D: T-wave alternans does not assess arrhythmic risk in patients with Brugada syndrome. Ann Noninvasive Electrocardiol 2004;9:162-165.
15. Ikeda T, Takami M, Sugi K, Mizusawa Y, Sakurada H, Yoshino H: Noninvasive risk stratification on subjects with a Brugada-type electrocardiogram and no history of cardiac arrest. Ann Noninvasive Electrocardiol 2005;10:396-403.
16. Verrier RL, Ikeda T: Ambulatory ECG-based T-wave alternans monitoring for risk assessment and guiding medical therapy: Mechanisms and clinical applications. Prog Cardiovasc Dis 2013;56:172-185.
17. Takasugi N, Kubota T, Nishigaki K, Verrier RL, Kawasaki M, Takasugi M, Ushikoshi H, Hattori A, Ojio S, Aoyama T, Takemura G, Minatoguchi S: Continuous T-wave alternans monitoring to predict impending life-threatening cardiac arrhythmias during emergent coronary reperfusion therapy in patients with acute coronary syndrome. Europace 2011;13:708-715.
18. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H,Wilde A: Brugada syndrome: Report of the second consensus conference. Heart Rhythm 2005;2:429-440.
19. ACC expert consensus document on signal averaged electrocardiography. J Am Coll Cardiol 1996;27:238-249.
20. Nearing BD, Verrier RL:Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy. J Appl Physiol 2002;92:541-549.
21. Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Jirasirirojanakorn K, Likittanasombat K, Bhuripanyo K, Ngarmukos T: Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation 2011;123:1270-1279.
22. Aiba T, Shimizu W, Hidaka I, Uemura K, Noda T, Zheng C, Kamiya A, Inagaki M, Sugimachi M, Sunagawa K: Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: High-resolution optical mapping study. J Am Coll Cardiol 2006;47:2074-2085.
23. Banville I, Gray RA: Effect of action potential duration and conduction velocity restitution and their spatial dispersion on alternans and the stability of arrhythmias. J Cardiovasc Electrophysiol 2002;13:1141-1149.
24. Antzelevitch C, Yan GX, Shimizu W: Transmural dispersion of repolarization and arrhythmogenicity: The Brugada syndrome versus the long QT syndrome. J Electrocardiol 1999;32:S158-S165.
25. Morita H, Morita ST, Nagase S, Banba K, Nishii N, Tani Y, Watanabe A, Nakamura K, Kusano KF, Emori T, Matsubara H, Hina K, Kita T, Ohe T: Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol 2003;42:1624-1631.
26. Chinushi M, Washizuka T, Okumura H, Aizawa Y: Intravenous administration of class I antiarrhythmic drugs induced T wave alternans in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2001;12:493-495.
27. Takagi M, Doi A, Takeuchi K, Yoshikawa J: Pilsicainide-induced marked T wave alternans and ventricular fibrillation in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2002;13: 837.
28. Ohkubo K, Watanabe I, Okumura Y, Yamada T, Masaki R, Kofune T, Oshikawa N, Kasamaki Y, Saito S, Ozawa Y, Kanmatsuse K: Intravenous administration of class I antiarrhythmic drug induced T wave alternans in an asymptomatic Brugada syndrome patient. Pacing Clin Electrophysiol 2003;26:1900-1903.
29. Nishizaki M, Fujii H, Sakurada H, Kimura A, Hiraoka M: Spontaneous T-wave alternans in a patient with Brugada syndrome-responses to intravenous administration of class I antiarrhythmic drug, glucose tolerance test, and atrial pacing. J Cardiovasc Electrophysiol 2005;16: 217-220.
30. Tada T, Kusano KF, Nagase S, Banba K, Miura D, Nishii N,Watanabe A, Nakamura K, Morita H, Ohe T: Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2008;19:56-61.
31. Morita H, Zipes DP, Lopshire J, Morita ST, Wu J: T wave alternans in an in vitro canine tissue model of Brugada syndrome. Am J Physiol Heart Circ Physiol 2006;291:H421-H428.
32. Fish JM, Antzelevitch C: Role of sodium and calcium channel block in unmasking the Brugada syndrome. Heart Rhythm 2004;1: 210-217.
33. Verrier RL, Nearing BD, Ghanem RN, Olson RE, Garberich RF, Katsiyiannis WT, Gornick CC, Tang CY, Henry TD: Elevated T-wave alternans predicts nonsustained ventricular tachycardia in association with percutaneous coronary intervention in ST-segment elevation myocardial infarction (STEMI) patients. J Cardiovasc Electrophysiol 2013;24:658-663.
34. Giudicessi JR, Ye D, Tester DJ, Crotti L, Mugione A, Nesterenko VV, Albertson RM, Antzelevitch C, Schwartz PJ, Ackerman MJ: Transient outward current (Ito) gain-of-function mutations in the KCND3- encoded Kv4.3 potassium channel and Brugada syndrome. Heart Rhythm 2011;8:1024-1032.
35. Ikeda T, Sakata T, Takami M, Kondo N, Tezuka N, Nakae T, Noro M, Enjoji Y, Abe R, Sugi K, Yamaguchi T: Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J Am Coll Cardiol 2000;35:722-730.
36. Nearing BD, Wellenius GA, Mittleman MA, Josephson ME, Burger AJ, Verrier RL. Crescendo in depolarization and repolarization heterogeneity heralds development of ventricular tachycardia in hospitalized patients with decompensated heart failure. Circ Arrhythm Electrophysiol 2012;5:84-90.
37. Weiss JN, Karma A, Shiferaw Y, Chen PS, Garfinkel A, Qu Z. From pulsus to pulseless: The saga of cardiac alternans. Circ Res 2006;98:1244-1253.
38. Postema PG,Wolpert C,Amin AS, Probst V, BorggrefeM, RodenDM, Priori SG, Tan HL, Hiraoka M, Brugada J, Wilde AA: Drugs and Brugada syndrome patients: Review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm 2009;6:1335-1341.
39. Postema PG, Neville J, de Jong JS, Romero K, Wilde AA, Woosley RL: Safe drug use in long QT syndrome and Brugada syndrome: Comparison of website statistics. Europace 2013;15:1042-1049.
40. Conte G, De Asmundis C, Sieira J, Levinstein M, Chierchia GB, Di Giovanni G, Baltogiannis G, Ciconte G, Saitoh Y, Casado-Arroyo R, Pappaert G, Brugada P: Clinical characteristics, management, and prognosis of elderly patients with brugada syndrome. J Cardiovasc Electrophysiol. 2014;25:514-519.